Happy Smooth Study

Infant Term Birth Clinical Trial

Official title:
Stool Composition and GI Tolerance in Infants Fed a Term Infant Formula With a New Fat Blend Plus L.Reuteri: a Randomized Controlled Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the stool composition and GI tolerance of an experimental formula with a new fat blend plus L. reuteri vs control formula.

Clinical Trial Description

Double-blind, randomized, controlled clinical trial. The purpose of this study is to evaluate the stool composition and GI tolerance of 140 healthy, term infants fed with an infant formula with a new fat blend plus L. reuteri vs a standard infant formula. All enrolled infants will participate in the trial for approximately 71 days. ;

Study Design

Related Conditions & MeSH terms

Infant Term Birth

Clinical Trial Details

NCT number	NCT03710551
Study type	Interventional
Source	Nestlé
Contact
Status	Completed
Phase	N/A
Start date	September 26, 2018
Completion date	July 21, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02598817` - Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula
Completed	`NCT03387124` - Breastfeeding Study
Completed	`NCT02670863` - Safety and Efficacy Study	N/A